Arcutis Biotherapeutics (ARQT) Research & Development (2019 - 2026)
Arcutis Biotherapeutics' Research & Development came in at $20.36 million for Q2 2026, up 4.6% from $19.45 million a year earlier but down 33.5% from the prior quarter.
Arcutis Biotherapeutics (ARQT) Research & Development (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arcutis Biotherapeutics reported Research & Development of $91.04 million, up 28.3% year-over-year; for FY2025, it came in at $77.05 million, up 0.8% from FY2024.
- Research & Development carries a five-year compound annual growth rate of -7.7% (FY2020 to FY2025).
- Going back by year, Research & Development was $76.42 million in FY2024 (-30.9%), $110.58 million in FY2023 (-39.4%), $182.44 million in FY2022 (+25.3%) and $145.56 million in FY2021 (+26.2%).
- The five-year range for quarterly Research & Development is $14.48 million (Q4 2024) to $69.73 million (Q3 2022).
- Year-over-year, Research & Development has increased for five consecutive quarters, with growth averaging 4.1% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q4 2021 (growth of 92.0%), and the weakest in Q3 2023 (a decline of 62.4%).
- Business Quant data shows ARQT's Research & Development at $30.63 million (Q1 2026), $20.45 million (Q4 2025) and $19.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Arcutis Biotherapeutics | 3.43 Bn | 2.72 Bn | 118.92 Mn | 20.36 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.36 Mn |
| Mar 31, 2026 | 30.63 Mn |
| Dec 31, 2025 | 20.45 Mn |
| Sep 30, 2025 | 19.60 Mn |
| Jun 30, 2025 | 19.45 Mn |
| Mar 31, 2025 | 17.54 Mn |
| Dec 31, 2024 | 14.48 Mn |
| Sep 30, 2024 | 19.50 Mn |
| Jun 30, 2024 | 19.30 Mn |
| Mar 31, 2024 | 23.14 Mn |
| Dec 31, 2023 | 23.78 Mn |
| Sep 30, 2023 | 26.24 Mn |
| Jun 30, 2023 | 25.22 Mn |
| Mar 31, 2023 | 35.35 Mn |
| Dec 31, 2022 | 33.88 Mn |
| Sep 30, 2022 | 69.73 Mn |
| Jun 30, 2022 | 38.21 Mn |
| Mar 31, 2022 | 40.62 Mn |
| Dec 31, 2021 | 52.56 Mn |
| Sep 30, 2021 | 40.60 Mn |
Arcutis Biotherapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ARQT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();